There are 413 resources available
86P - Phyllodes tumours: understanding more about the unknown.
Presenter: Soomin Jang
Session: Poster viewing and lunch
87P - Breaking Down the Divide: An Analysis of Male Breast Cancer Demographics and Survival by Race in United States
Presenter: Lekha Yadukumar
Session: Poster viewing and lunch
88P - Male Breast Cancer - A Rare Conundrum.
Presenter: MINU MUDDABHAKTUNI
Session: Poster viewing and lunch
89P - Inclusion of racial and ethnic minorities in European Breast Cancer Clinical Trials
Presenter: Angeliki Bania
Session: Poster viewing and lunch
90P - Is physician-patient language concordance better for clinical trial enrollment in breast cancer patients?: A real- life study
Presenter: Daniela Urueta Portillo
Session: Poster viewing and lunch
91P - The lack of documentation of patient’s body mass index (BMI) in recent clinical trials
Presenter: Josephine Van Cauwenberge
Session: Poster viewing and lunch
92P - The impact of a micro CME activity on physician knowledge and competence regarding new data in the early and metastatic breast cancer
Presenter: Mohamed Dewji
Session: Poster viewing and lunch
97P - Efficacy and safety of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer: Long-term data from the PHranceSCa study
Presenter: Leonor Ribeiro
Session: Poster viewing and lunch
98P - Real-world effectiveness and safety of neratinib in the extended adjuvant treatment of patients with HER2+ early breast cancer (eBC) in the United States Community Oncology Setting
Presenter: Diana Luftner
Session: Poster viewing and lunch
99P - Exploratory analysis of differential gene expression (DGE) and non-negative matrix factorisation (NMF) clustering in KATHERINE: Adjuvant trastuzumab emtansine (T-DM1) vs. trastuzumab (H) in patients with HER2-positive residual invasive breast cancer after neoadjuvant treatment (NAT)
Presenter: Mark Basik
Session: Poster viewing and lunch